Cagrilintide 5mg / Semaglutide 5mg

Timing: Morning    Frequency: Once weekly    Duration: 12–16 weeks, followed by assessment

A combination of a long-acting amylin analog and a GLP-1 receptor agonist. Cagrilintide slows gastric emptying and enhances satiety; paired with semaglutide's incretin action, research suggests synergistic effects on appetite regulation and body composition.

Notes: Cagrilintide is potent — start low and evaluate. A 0.3 mL syringe improves dosing accuracy at small volumes.